Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
TAH-1005 by Alpha Fusion for Follicular Thyroid Cancer: Likelihood of Approval
TAH-1005 is under clinical development by Alpha Fusion and currently in Phase I for Follicular Thyroid Cancer. According to GlobalData,...
Data Insights
TAH-1005 by Alpha Fusion for Papillary Thyroid Cancer: Likelihood of Approval
TAH-1005 is under clinical development by Alpha Fusion and currently in Phase I for Papillary Thyroid Cancer. According to GlobalData,...